Explore how patient voices and EOS Network's collaboration at UEG's Digestive Health Roundtable 2025 are transforming care, research, and policy across Europe. Read more
Discover EOS Network's impact at UEG Week 2025, highlighting advances in eosinophilic research, patient advocacy, and multidisciplinary collaboration. Read more
EOS Network attended the IES Congress 2025 in Montpellier, representing the global patient voice and connecting with researchers to advance eosinophilic disease care and collaboration. Read more
Discover a narrative review on the link between atopic dermatitis and eosinophilic oesophagitis, from shared pathways to treatments. Read more
Discover a position paper urging policy change for better diagnosis, treatment, and care of Eosinophilic Oesophagitis (EoE), developed by a coalition of international experts and patient advocates. Read more
Honouring Olena Filatova's contributions as Communications Officer over the last three years. Read more
A heartfelt thank you to Pippa Dennitts for her dedicated 5 years of support and guidance as Trustee of EOS Network. Read more
Healthcare Transition Campaign - a united effort to raise awareness, promote structured transition planning, and improve outcomes for young patients and their families. Read more
New 2025 review shows why oral steroids in severe asthma should be minimised, highlighting risks, costs, and safer alternatives like biologics. Read more
Discover how the oesophagus plays a critical immunological role beyond food transport, maintaining homeostasis and immune tolerance to food. Read more
Discover how the EOS Network strengthened global connections and promoted Eosinophilic Gastrointestinal Disease advocacy at the European Society for Paediatric Gastroenterology, Hepatology and Nutrition - ESPGHAN 2025 Annual Meeting in Helsinki. Read more
A new update from NS Pharma announces FDA Orphan Drug Designation for NS-229, a JAK1 inhibitor being studied for eosinophilic granulomatosis with polyangiitis (EGPA). Read more
A new study using EGID Partners data reveals that segmental overlap in EGIDs is common, especially in non-EoE cases, and is associated with greater symptom burden, higher anxiety levels, and increased use of systemic steroids and biologics. Read more
Urgent appeal for USA citizens to reach out to Congress to reconsider their decision to cancel the funding application for CEGIRs life-changing Eosinophilic Gastrointestinal Research Projects. Take action today! Read more
A new study from Sheffield Children’s Hospital explores how atopy influences EoE symptoms and treatment outcomes in children, with insights on elimination diets. Read more
Contribute to research on Eosinophilic Esophagitis and help develop a decision-assisting tool. Share your insights to improve care and patient outcomes. Read more
A new study suggests that eliminating just one food (milk) may be as effective as a four-food elimination diet for some outcomes in children with Eosinophilic Osophagitis (EoE). Learn how this research could impact dietary management and quality of life. Read more
Eosinophilic-Associated Diseases (EADs) extend beyond the gut, linking other inflammatory T2 conditions like EoE, asthma, and atopic dermatitis. Learn about evolving research, diagnosis challenges, and targeted biologic treatments that are transforming patient care. Read more
This review explores the role of early EoE screening in atopic patients and a multidisciplinary approach using dupilumab to improve patient outcomes and quality of life. Read more
A new AGA expert review provides best practice advice on diagnosing and managing oesophageal dysfunction caused by immune-mediated diseases and infections. Read more
Discover insights on a newly developed screening tool designed to facilitate the diagnosis and management of T2 inflammation Eosinophilc associated diseases. Read more
Discover findings from the SWALLeOeW EoE study, exploring diagnostic tests like manometry and 24-hour pH impedance testing and patient experiences. Read more
Aquestive Therapeutics announces positive topline results from a study evaluating Anaphylm™, a sublingual epinephrine film, as a potential alternative to traditional epinephrine EPI or Jext Pen delivery methods for managing Oral Allergy Syndrome. Read more
Discover the study findings comparing benralizumab (ABRA) and prednisolone in treating eosinophilic exacerbations of asthma and COPD. Read more